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Abstract
The RNA triphosphatase component of vaccinia virus mRNA capping enzyme (the product of the viral D1 gene) belongs to a family
of metal-dependent phosphohydrolases that includes the RNA triphosphatases of fungi, protozoa, Chlorella virus, and baculoviruses. The
family is defined by two glutamate-containing motifs (A and C) that form the metal-binding site. Most of the family members resemble the
fungal and Chlorella virus enzymes, which have a complex active site located within the hydrophilic interior of a topologically closed
eight-stranded  barrel (the so-called “triphosphate tunnel”). Here we queried whether vaccinia virus capping enzyme is a member of the
tunnel subfamily, via mutational mapping of amino acids required for vaccinia triphosphatase activity. We identified four new essential side
chains in vaccinia D1 via alanine scanning and illuminated structure–activity relationships by conservative substitutions. Our results,
together with previous mutational data, highlight a constellation of six acidic and three basic amino acids that likely compose the vaccinia
triphosphatase active site (Glu37, Glu39, Arg77, Lys107, Glu126, Asp159, Lys161, Glu192, and Glu194). These nine essential residues are
conserved in all vertebrate and invertebrate poxvirus RNA capping enzymes. We discerned no pattern of clustering of the catalytic residues
of the poxvirus triphosphatase that would suggest structural similarity to the tunnel proteins (exclusive of motifs A and C). We infer that
the poxvirus triphosphatases are a distinct lineage within the metal-dependent RNA triphosphatase family. Their unique active site, which
is completely different from that of the host cell’s capping enzyme, recommends the poxvirus RNA triphosphatase as a molecular target for
antipoxviral drug discovery.
© 2003 Elsevier Science (USA). All rights reserved.
Introduction
The 5 m7G cap is a distinctive feature of eukaryotic
cellular and viral messenger RNA, which is required for
mRNA stability and efficient translation. The cap is formed
by modification of nascent pre-mRNAs as they are synthe-
sized by cellular or viral RNA polymerases (Hagler and
Shuman, 1992; Chiu et al., 2002). Capping entails three
enzymatic reactions: (i) the 5 triphosphate end of the pre-
mRNA is hydrolyzed to a diphosphate by RNA 5 triphos-
phatase; (ii) the diphosphate RNA end is capped with GMP
by RNA guanylyltransferase; and (iii) the GpppN cap is
methylated by RNA (guanine-N7) methyltransferase (Shu-
man, 2001). Certain DNA viruses encode their own cap-
forming enzymes; these include poxviruses, African swine
fever virus, baculoviruses, infectious spleen and kidney
necrosis virus, and Chlorella virus PBCV-1 (Shuman,
2002).
Poxviruses replicate in the cytoplasm and they encapsi-
date within the infectious virion all the enzymes required for
the synthesis of early mRNAs, including an RNA polymer-
ase, a poly(A) polymerase, and an mRNA capping enzyme
with triphosphatase, guanylyltransferase, and methyltrans-
ferase activities (Moss, 2001). Vaccinia capping enzyme is
a heterodimer of 97-kDa (844-aa) and 33-kDa (287-aa)
polypeptides encoded by the D1 and D12 genes, respec-
tively. The D1 and D12 genes are essential for vaccinia
replication (Carpenter and DeLange, 1991; Hassett et al.,
1997). The amino-terminal fragment of the D1 subunit from
residues 1–545 constitutes an autonomous bifunctional do-
main with triphosphatase and guanylyltransferase activities
(Myette and Niles, 1996a, 1996b). The triphosphatase and
guanylyltransferase active sites are distinct, insofar as mu-
tations have been identified that inactivate the triphos-
phatase, but spare the guanylyltransferase, while other mu-
tations inactivate the guanylyltransferase, but spare the
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triphosphatase (Cong and Shuman, 1995; Yu et al., 1997).
The triphosphatase active site is located in the N-terminal
half of the domain (Fig. 1), whereas the guanylyltransferase
active site resides in the C-terminal half.
Vaccinia RNA triphosphatase belongs to a family of
metal-dependent phosphohydrolases that includes the RNA
triphosphatase components of the capping enzymes of fungi
(Saccharomyces cerevisiae, Candida albicans, Schizosac-
charomyces pombe), protozoan and microsporidian para-
sites (Plasmodium falciparum, Trypanosoma brucei, Leish-
mania major, Encephalotozoon cuniculi), and DNA viruses
(poxviruses, African swine fever virus, baculoviruses,
Chlorella virus) (Shuman, 2001, 2002). The defining struc-
tural features of the metal-dependent RNA triphosphatases
are two glutamate-containing motifs (A and C in Fig. 1) that
comprise the metal-binding site and are required for catal-
ysis by all family members. The A and C motifs were
identified originally by mutational analysis of vaccinia RNA
triphosphatase (Yu and Shuman, 1996).
The solution of the crystal structure of the S. cerevisiae
RNA triphosphatase Cet1 revealed that its active site is
located within a topologically closed hydrophilic tunnel
composed of eight antiparallel  strands (Lima et al., 1999).
The “triphosphate tunnel” has a distinctive architecture sup-
ported by an intricate network of hydrogen bonds and elec-
trostatic interactions within the cavity, of which a high
proportion are required for the catalytic activity of Cet1
(Bisaillon and Shuman, 2001). A single sulfate ion in the
Fig. 1. Conservation of primary structure among poxvirus RNA triphosphatases. The amino acid sequence of the capping enzyme large subunit of vaccinia
virus from aa 30 to 199 is aligned with the related polypeptides encoded by other poxviruses: Yaba-like virus (ya), molluscum contagiosum virus (mc), lumpy
skin disease virus (ls), swinepox virus (sp), fowlpox virus (fp), Amsacta moorei entomopoxvirus (Am), and Melanoplus sanguinipes entomopoxvirus (Ms).
Positions of side chain identity or similarity in all the aligned poxvirus proteins are denoted by ^ below the alignment. The amino acids of vaccinia capping
enzyme that were mutated to alanine in the present study are indicated by an exclamation point. Residues defined previously as essential for the triphosphatase
activity of vD1 are denoted by F; unimportant residues are indicated by . The nine essential side chains proposed to comprise the triphosphatase active
site are highlighted in shaded boxes. The metal-binding motifs A and C are depicted as probable  strands (horizontal arrows). Two other candidate  strands
are indicated by arrows and a question mark.
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tunnel (which mimics the  phosphate of the substrate) is
coordinated by multiple basic side chains projecting into the
cavity. A manganese ion within the tunnel cavity is coor-
dinated with octahedral geometry to a sulfate, to the side
chain carboxylates of the two glutamates in motif A, and to
a glutamate in motif C.
Amino acid sequence comparisons and mutational anal-
yses of the RNA triphosphatases from fungi, microsporidia,
protozoa, and Chlorella virus highlight the conservation of
the  stands that compose the triphosphate tunnel of yeast
Cet1 (Shuman, 2001; see also Fig. 7 below). Thus, it is
proposed that the active site folds of the fungal, microspro-
dian, protozoan, and Chlorella virus RNA triphosphatases
are conserved as  barrels, implying a common evolution-
ary origin for these enzymes (Shuman, 2002). An extensive
mutational analysis of the Chlorella virus RNA triphos-
phatase suggests strongly that its active site architecture and
catalytic mechanism adhere closely to that of yeast Cet1
(Gong and Shuman, 2002).
In contrast, the RNA triphosphatases of poxviruses and
baculoviruses have little primary structure similarity to the
fungal, microsporidian, protozoal, and Chlorella virus en-
zymes. The poxvirus and baculovirus triphosphatases do
contain the diagnostic metal-binding motifs A and C com-
posed of alternating glutamate/hydrophobic side chains; in-
deed, mutational studies of the poxvirus and baculovirus
proteins are consistent with an essential role for the con-
served glutamates in metal binding (Ho et al., 2000; Jin et
al., 1998; Martins and Shuman, 2001). However, the pox-
virus and baculovirus enzymes do not have obvious equiv-
alents of the other six  strands that compose the tunnel
found in the yeast enzyme and its homologs. The structural
and mechanistic relatedness among the various DNA virus
RNA capping enzymes is of interest to us for two reasons:
(i) it may illuminate the evolutionary connections between
different families of large DNA viruses (Shuman, 2002) and
(ii) RNA triphosphatase is an attractive target for antiinfec-
tive drug discovery (Shuman, 2001) and, especially, for the
discovery of new agents that are active against smallpox.
Here we set out to map the essential constituents of the
triphosphatase component of vaccinia virus capping en-
zyme. The rationale was that by defining the catalytic res-
idues of the poxvirus triphosphatase, we might either: (i)
uncover otherwise hidden similarities to the active site of
the tunnel subfamily or (ii) establish that the poxvirus RNA
triphosphatase comprises a separate lineage within the met-
al-dependent RNA triphosphatase family. We performed an
alanine scan of 10 residues within the N-terminal segment
of vD1(1–545) that are conserved in other poxvirus capping
enzymes. We thereby identified four new side chains re-
quired for triphosphatase activity: Lys107, Glu126, Asp159,
and Lys161. Structure–activity relationships were clarified
by conservative substitutions. These results, together with
previous mutational studies, highlight an active site com-
posed of nine hydrophilic amino acids. We can discern no
pattern of clustering of the catalytic residues of the poxvirus
triphosphatase similar to that of the tunnel subfamily, ex-
clusive of motifs A and C. We propose that the poxvirus
triphosphatases are a distinct lineage within the metal-de-
pendent RNA triphosphatase family.
Results
Mutagenesis strategy
Prior mutational analyses of vaccinia D1(1–545) had
identified the motif A and C glutamates plus a single basic
residue (Arg77) as essential for the triphosphatase reaction
(Yu and Shuman, 1996; Yu et al., 1997; Ho et al., 2000).
Alanine mutations at Glu37, Glu39, Arg77, Glu192, and
Glu194 (denoted by · in Fig. 1) abrogated the triphosphatase
activity of D1(1–545), but not the guanylyltransferase ac-
tivity. Eight other residues located in the segment between
motifs A and C of vD1(1–545) were subjected to alanine-
scanning and found to be unimportant for triphosphatase
activity (these are denoted by  in Fig. 1). Subsequent
comprehensive mutational analyses of the S. cerevisiae and
Chlorella virus RNA triphosphatases have shown that all of
the side chains that compose the active site are located
within the polypeptide segment spanning motifs A and C
(Bisaillon and Shuman, 2001; Gong and Shuman, 2002).
However, this region of vaccinia D1(1–545) bears no re-
semblance to either yeast or Chlorella virus RNA triphos-
phatase. Given that the active sites of the yeast and Chlor-
ella virus triphosphatases are composed of 12–15 essential
amino acids, our working hypothesis is that the active site of
the poxvirus triphosphatase component has not yet been
fully delineated. The goal of the present study was to extend
the functional map of the vaccinia triphosphatase active site
by introducing new mutations into the N-terminal triphos-
phatase segment of vD1(1–545). The choice of residues to
be mutated was made by aligning the sequences of the
capping enzyme large subunits from different genera of
poxviruses (Fig. 1).
The large number of poxvirus genera affords an oppor-
tunity for phylogenetic analysis. The poxviruses consist of
two subfamilies: vertebrate poxviruses (Chordopoxvirinae)
and insect poxviruses (Entomopoxvirinae). Capping en-
zyme large subunit genes have been sequenced for many
members of the Orthopoxvirus genus, including vaccinia,
monkeypox, camelpox, cowpox, ectromelia, variola major
and variola minor. The orthopoxvirus capping enzymes are
99–100% identical in the region corresponding to the pu-
tative triphosphatase “domain” of vaccinia D1 (aa 30–199)
shown in Fig. 1. Sequences are also available from other
genera of vertebrate poxviruses, including: Shope fibroma
virus and myxoma virus (Leporipoxvirus), Yaba-like virus
(Yatapoxvirus), lumpy skin disease virus and sheeppox vi-
rus (Capripoxvirus), swinepox (Suipoxvirus); fowlpox (Avi-
poxvirus), and molluscum contagiosum virus (Molluscipox-
virus). The capping enzyme large subunits from different
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genera of chordopoxviruses display from 49 to 67% amino
acid identity with vD1(30–199). The genus B entomopox-
viruses, which infect moths and grasshoppers, includes the
Amsacta moorei entomopoxvirus (AmEPV) and the Mela-
noplus sanguinipes entomopoxvirus (MsEPV). The capping
enzyme large subunits of the EPVs are only 22% identical
to vD1(30–199). An alignment of the vD1(30–199) se-
quence to the entomopoxvirus proteins and selected chor-
dopoxvirus enzymes is shown in Fig. 1. The 43 positions of
side-chain identity/similarity in all eight proteins are de-
noted by ^ below the aligned sequences. The invariant
positions include all of the five residues already known to be
essential for triphosphatase activity. In contrast, only three
of the eight residues that are dispensable for triphosphatase
activity are conserved.
In picking residues to target in the present study, we
focused exclusively on charged and polar amino acids,
because such functional groups compose the active site of
Cet1 and they are most likely to be direct participants in
NTP binding and catalysis of  phosphate hydrolysis. We
then used one of two additional criteria for target selection:
(i) conservation in all poxvirus orthologs; and/or (ii) loca-
tion within possible -strand secondary structure, as sug-
gested by the presence of alternating hydrophilic and hy-
drophobic side chains. A total of 10 residues were subjected
to alanine scanning: Asn35, Asp89, Lys91, Asn92, Lys107,
Glu126, Asp159, Lys161, Lys163, and Lys184.
Alanine scanning identifies four new residues required for
triphosphatase activity
Wild-type vD1(1–545) and the 10 Ala mutants were
produced in bacteria as His10-tagged fusions and purified
from soluble bacterial extracts by Ni–agarose chromatogra-
phy and glycerol gradient sedimentation. SDS–PAGE anal-
ysis of the peak glycerol gradient fractions showed that the
preparations were highly enriched with respect to the-63
kDa vD1(1–545) polypeptide (Fig. 2A; see Fig. 5A for
K107A). The guanylyltransferase activity of each of the
mutant protein preparations was demonstrated by label
transfer from [-32P]GTP to the enzyme to form a covalent
enzyme–GMP complex (Fig. 2B; Fig. 5B for K107A). The
guanylyltransferase specific activity of each mutant protein
was determined by enzyme titration (Fig. 3). The slopes of
the titration curves were normalized to the specific activity
of wild-type vD1(1-545) (Table 1). The findings that all of
the mutant enzymes retained full guanylyltransferase activ-
ity indicated that none of the 10 Ala mutations affected the
global folding of the recombinant vaccinia protein.
The triphosphatase activities of wild type vD1(1–545)
and the vD1(1–545)–Ala mutants were assayed by the re-
lease of 32Pi from [32P]ATP (1 mM) during a 30-min
reaction in the presence of 10 mM magnesium chloride. The
specific activities of wild-type and mutant vD1(1–545) pro-
teins were calculated from the slopes of the titration curves
in the linear range of enzyme dependence (Fig. 4). The
relative specific activities of the vD1(1–545) mutants (nor-
malized to the wild type) are shown in Table 1. We found
that whereas six of the Ala mutants retained substantial
triphosphatase activity (N35A, D89A, K91A, N92A,
K163A, and K184A), four of the mutants were obviously
defective (K107A, E126A, D159A, and K161A). The
ATPase activities of the K107A, and E126A mutants were
0.5% of wild-type D1(1–545). K161A and D159A were 2
and 11% as active as wild-type, respectively. We conclude
that: (i) Lys107, Glu126, Asp159, and Lys163 are important
for -phosphate cleavage and (ii) Asn35, Asp95, Asn91,
Lys92, Lys163, and Lys184 are dispensable for triphos-
phatase function in vitro.
The present finding that the K161A mutation inactivates
the triphosphatase, but spares the guanylyltransferase, was
at odds with the previous report that a F160A–K161A
double-mutation inactivated the guanylyltransferase, but
Fig. 2. Purification and guanylytransferase activities of wild-type and
alanine mutant D1(1–545) proteins. (A) Aliquots (1 g) of the peak
glycerol gradient fractions of wild-type (WT) vD1(1–545) and the indi-
cated mutants were analyzed by SDS–PAGE. Polypeptides were visualized
by staining with Coomassie blue dye. The positions and sizes (in kDa) of
marker proteins are indicated on the left. (B) Enzyme–GMP complex
formation. Reaction mixtures (20 l) containing 50 mM Tris–HCl (pH
8.0), 5 mM DTT, 5 mM MgCl2, 5 M [32P]GTP, and 200 ng of WT or
mutant vD1(1–545) as specified were incubated for 5 min at 37°C. The
reactions were quenched with SDS and the products were analyzed by
SDS–PAGE. An autoradiograph of the dried gel is shown. The positions
and sizes of marker polypeptides are indicated on the left.
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spared the triphosphatase (Yu and Shuman, 1996). To re-
solve the discrepancy, we expressed and purified the K161A
mutant protein twice from independent bacterial transfor-
mants. Each preparation of K161A was equally defective
for triphosphatase function and retained guanylyltransferase
activity. We then reconstructed the expression plasmid for
the F160A–K161A double-mutant and produced the recom-
binant protein in bacteria. We found it to be insoluble and
therefore not amenable to purification. In light of these
findings, we conclude that the previous results concerning
the F160A–K161A are incorrect. (The earlier finding may
be attributable to inadvertent use of the guanylyltransferase
active site mutant K260A, which was included as a gua-
nylyltransferase-defective control in the previous work.)
Effects of conservative mutations of Lys107, Glu126,
Asp159, and Lys161
To further evaluate the contributions of Lys107, Glu126,
Asp159, and Lys161 to the triphosphatase reaction, we
tested the effects of conservative substitutions. Aspartate
was replaced by asparagine and glutamine, glutamate by
glutamine and aspartate, and lysine by arginine and glu-
tamine. The K107R, K107Q, E126D, E126Q, D159E,
D159N, K161R, and K161Q proteins were purified from
soluble bacterial extracts by Ni–agarose chromatography
and glycerol gradient sedimentation (Fig. 5A). All eight of
the conservative mutants retained guanylyltransferase activ-
ity, again testifying to the absence of a global folding
problem (Fig. 5B and Table 2).
The triphosphatase specific activities were determined by
enzyme titration (Fig. 6 and Table 2). We found that K107R
and K107Q were just as defective as the alanine mutant,
with 0.5% of wild-type triphosphatase activity. K161Q
was as defective as K161A (2% activity) and the K161R
mutant was only marginally better (8% of wild-type activ-
ity). Thus, lysine is specifically required at positions 107
and 161 of the vaccinia triphosphatase. Note that lysine is
strictly conserved at these two positions in all other poxvi-
rus capping enzymes (Fig. 1). Conservative replacement of
Glu126 with Asp or Gln elicited a severe catalytic defect
comparable to that seen with E126A (0.7–0.9% of wild-
type activity). These data establish a requirement for a
carboxylate residue at position 126 and they indicate a
minimum distance requirement from the main chain to the
carboxylate that is met by glutamate but not aspartate.
Glu126 is invariant in all other poxvirus capping enzymes.
Replacing Asp159 by asparagine was more deleterious than
the alanine change (2% activity for D159N versus 11% for
D159A), but activity was restored completely by the gluta-
mate substitution. We surmise that a carboxylate is impor-
tant for function and that the longer glutamate side chain
can be accommodated at position 159 with no detrimental
effect. Note that the equivalent position is naturally occu-
Table 1
Effects of alanine mutations on D1 phosphohydrolase activity
Mutant GTase (% of WT) ATPase (% of WT)
N35A 130 110
D89A 100 88
K91A 130 85
N92A 160 80
K107A 83 0.5
E126A 120 0.5
D159A 110 11
K161A 98 2
K163A 130 99
K184A 110 100
Note. The guanylyltransferase (GTase) specific activities were calculated
from the titration data in Fig. 3 and normalized to the wild-type value.
ATPase specific activities were calculated from the titration data in Fig. 4
and normalized to the wild-type value (7.3 s1).
Fig. 3. Titration of guanylyltransferase activity. Guanylyltransferase reac-
tions contained 5, 10, or 20 ng of the WT or mutant vD1(1–545) proteins.
The yield of enzyme–[32P]guanylate complex was quantitated by scanning
the SDS gel with a phosphorimager and plotted as a function of input
enzyme (63 ng of protein  1 pmol of enzyme). Each datum is the average
of two titration experiments. We calculated that 50% of the input wild-type
vD1(1–545) molecules became guanylated with labeled GMP during the
reaction.
129C. Gong, S. Shuman / Virology 309 (2003) 125–134
pied by glutamate in the two entomopoxvirus capping en-
zymes (Fig. 1).
Discussion
By performing a mutational analysis of 10 hydrophilic
residues of the vaccinia D1 protein that are conserved in
most or all of the known poxvirus orthologs, we have
identified four new amino acids that are essential for
triphosphatase activity. These results, together with previ-
ous mutational studies (Ho et al., 2000), highlight a con-
stellation of 9 charged amino acids (shaded in Fig. 1) that
are likely to compose the triphosphatase active site: Glu37,
Glu39, Arg77, Lys107, Glu126, Asp159, Lys161, Glu192,
and Glu194. Structure–activity relationships have been de-
termined at all essential positions by gauging the effects of
conservative side-chain substitutions. The 9 essential resi-
dues are conserved in all poxvirus mRNA capping enzymes.
We hypothesize that these residues participate directly in
catalysis of  phosphate hydrolysis. (Note that by using
ATP as the substrate to measure mutational effects on
triphosphatase activity, we have focused on the require-
Fig. 4. Effects of alanine mutations on triphosphatase activity. Reaction
mixtures (10 l) containing serial twofold dilutions of enzyme as specified
were incubated for 30 min at 37°C. The release of 32Pi is plotted as a
function of input enzyme. Each datum is the average of two titration
experiments.
Fig. 5. Purification and guanylyltransferase activities of K107A and con-
servatively mutated D1(1–545) proteins. (A) Aliquots (1 g) of the peak
glycerol gradient fractions of WT vD1(1–545) and the indicated mutants
were analyzed by SDS–PAGE. Polypeptides were visualized by staining
with Coomassie Blue dye. (B) Guanylyltransferase reactions were per-
formed as described in Fig. 2. An autoradiograph of the dried SDS–gel is
shown.
Table 2
Effects of conservative mutations on D1 phosphohydrolase activity
Mutant GTase (% of WT) ATPase (% of WT)
K107R 87 0.5
K107Q 69 0.5
E126D 92 0.7
E126Q 90 0.9
D159E 130 110
D159N 110 2
K161R 80 8
K161Q 150 2
Note. Guanylyltransferase (GTase) specific activities of the conservative
mutants were gauged as described in Fig. 3 and normalized to the wild-type
value. ATPase specific activity was calculated from the titration data in
Fig. 6 and normalized to the wild-type value (12 s1).
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ments for phosphohydrolase reaction chemistry. It is con-
ceivable that other residues contribute uniquely to the af-
finity of vD1(1–545) for RNA substrates and that these are
not revealed in the present study.) Having now mutated each
and every one of the strictly conserved charged residues
within the N-terminal triphosphatase domain of vD1, we
believe that most, if not all, of the catalytic amino acids are
presently identified. None of the mutations that affected
triphosphatase activity had any significant impact on the
guanylyltransferase component of the vaccinia capping en-
zyme, again underscoring the independence of the triphos-
phatase and guanylyltransferase active sites.
Although a phosphohydrolase active site composed of 9
essential functional groups may appear to be unduly com-
plex, the putative poxvirus active site is actually less ba-
roque than that of the yeast RNA triphosphatase, which
consists of 15 essential hydrophilic side chains that emanate
from the 8  strands that form the triphosphate tunnel
(Bisaillon and Shuman, 2001). A structure-based alignment
of the sequences of the members of the tunnel family of
RNA triphosphatases is shown in Fig. 7, with the  strands
of the tunnel denoted by arrows and the essential side chains
of Cet1 indicated by dots. Ten of the fifteen essential side
chains of Cet1 make direct or water-mediated contacts with
the enzyme-bound metal cofactor, the  phosphate, or the
putative nucleophilic water. These 10 residues include 4
glutamates and an aspartate that bind the metal cofactor
either directly or via water, 2 arginines and a lysine that
contact the  phosphate directly, and 1 aspartate and 1
glutamate that coordinate phosphate-interacting waters, one
of which is the putative nucleophile in  phosphate hydro-
lysis. The other 5 essential residues appear to stabilize the
tunnel architecture and are not implicated directly in catal-
ysis (Bisaillon and Shuman, 2001). Thus, the complexity of
the poxvirus and Cet1 active sites are comparable, when one
considers that the poxvirus active site may not adopt a
tunnel fold (see below).
The vaccinia triphosphatase active site consists of six
acidic and three basic functional groups. The vaccinia motif
A and C glutamates (Glu37, Glu39, Glu192, and Glu194)
are implicated in metal-binding on the basis of previous
mutational studies (Ho et al., 2000) and their overt similar-
ity to the metal-binding  strands of Cet1 (1 and 11 in
Fig. 7). We speculate that Asp159 of the vaccinia enzyme
may also participate in metal binding. We propose that the
three essential basic side chains (Arg77, Lys107, and
Lys161) interact with the  phosphate and stabilize the
transition state. We posit a role for Glu126 as a general base
catalyst to activate the nucleophilic water for its attack on
the  phosphorus (analogous to the general base function
postulated for the essential glutamate in the 8 strand of the
tunnel enzymes).
Are any of the essential constituents of vaccinia triphos-
phatase (other than those in motifs A and C) likely to be
located in  strands? Now that the active site is defined, can
we detect any structural similarities between the poxvirus
triphosphatases and the tunnel subfamily of RNA triphos-
phatases? Our inspection of the sequences surrounding the
essential vaccinia triphosphatase residues hints that the pep-
tide motif 158IDFKLKY164, which is the single best-con-
served sequence element in the alignment of the chordopox-
virus and entomopoxvirus polypeptides (see Fig. 1), is a
likely candidate to adopt a  secondary structure. The pres-
ence of alternating hydrophobic and hydrophilic side chains
could allow the projection of the hydrophilic side chains
into the enzyme’s active site, while the hydrophobic resi-
dues on the opposite face could project into the enzyme’s
core. Although this candidate  strand includes two essen-
tial side chains (Asp159 and Lys161), its sequence bears no
resemblance to any of the conserved  strands of the tunnel
enzyme subfamily (see Fig. 6). Similar considerations point
to the vaccinia peptide motif 74VKIRTKI80 as another can-
didate  strand (Fig. 1). Whereas the pattern of three alter-
Fig. 6. Effects of conservative mutations on triphosphatase activity. The
release of 32Pi is plotted a function of input protein. Each datum is the
average of two titration experiments.
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nating positively charged side chains in this motif is similar
to that of the 9 strand of the tunnel subfamily enzymes
(Fig. 7), they are unlikely to be structurally or functionally
equivalent, insofar as: (i) only one of the basic residues is
essential for vaccinia triphosphatase, whereas all three are
important for yeast Cet1, and (ii) the location of the basic
motifs relative to the two metal-binding motifs A and C is
quite different in the poxvirus and tunnel subfamily triphos-
phatases. The remaining two essential side chains of the
vaccinia triphosphatase are situated within clusters of
charged residues and their immediate context bears no con-
vincing resemblance to any of the  strands of the tunnel
subfamily.
Our results underscore the structural differences between
poxvirus RNA triphosphatases and the tunnel subfamily of
RNA triphosphatases. The tunnel enzyme group embraces
capping enzymes across a wide evolutionary landscape,
including the RNA triphosphatase of Chlorella virus
PBCV-1. Our inference is that the poxvirus triphosphatases
lack a topologically closed tunnel architecture. Although the
poxvirus active site may well retain a significant component
of  secondary structure, we are unable to discern any
amino acid sequence similarity to the Chlorella virus, pro-
tozoan, and fungal enzymes, exclusive of metal-binding
motifs A and C. Whether the emergence of a distinct pox-
virus branch of the metal-dependent triphosphate family
reflects divergence from a common ancestor or convergence
toward a common metal-binding site cannot be surmised at
present. A common origin for the poxviruses and Chlorella
virus familes has been proposed based on the hypothesis of
a set of shared gene products (predominantly enzymes) that
existed in their last common ancestor virus (Iyer et al.,
2001). Our mutational analyses showing that the Chlorella
virus triphosphatase is closely related to the yeast enzyme
(Gong and Shuman, 2002) and that the poxvirus RNA
triphosphatase belongs to a separate subfamily are not im-
Fig. 7. The triphosphate tunnel subfamily of metal-dependent RNA triphosphatases. The amino acid sequence of the catalytic domain of S. cerevisiae RNA
triphosphatase Cet1 is aligned to the sequences of C. albicans CaCet1, S. cerevisiae Cth1, S. pombe Pct1, P. falciparum Prt1, Chlorella virus cvRtp1,
Encephalitozoon cuniculi Cet1, Trypanosoma brucei Cet1, and Leishmania major Cet1. Gaps in the alignment are indicated by dashes. Nonconserved inserts
in PfPrt1 and LmCet1 are omitted from the alignment and are denoted by . The  strands that form the triphosphate tunnel of ScCet1 are denoted above
the sequence. Peptide segments with the highest degree of conservation in all tunnel subfamily proteins are highlighted by the shaded boxes. Essential
hydrophilic amino acids of the Cet1 active site are denoted by dots above the sequence.
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mediately consistent with a simple common origin for the
respective viral RNA capping systems. Indeed, the trifunc-
tional poxvirus capping enzyme large subunit is most sim-
ilar in its domain organization to the capping enzymes of the
cytoplasmic DNA plasmids of fungi (Tigemann et al.,
2001); this similarity has prompted a suggestion that pox-
viruses are descendants of cytoplasmic episomes (Shuman,
2002).
The metal-dependent RNA triphosphatases are recom-
mended as potential targets for antifungal, antiprotozoal,
and antiviral drugs that would selectively interfere with the
capping of pathogen mRNAs (Shuman, 2001). RNA
triphosphatase is an especially attractive therapeutic target
for smallpox because: (i) the active site structure and cata-
lytic mechanism of poxvirus RNA triphosphatase are com-
pletely different from the RNA triphosphatase domain of
the metazoan host cell RNA capping enzyme (Changela et
al., 2001) and (ii) metazoan species encode no identifiable
homologs of the poxvirus RNA triphosphatase. Thus, a
mechanism-based inhibitor of the vaccinia RNA triphos-
phatase should be highly selective and have minimal effect
on the human host. The 100% sequence identity between the
vaccinia D1 triphosphatase domain and the variola ortholog
virtually ensures that an inhibitor of the vaccinia RNA
triphosphatase will be active against the variola enzyme.
Development of molecular targets for treatment of poxvirus
infections has become a pressing issue, given the concerns
that smallpox could be used as a bioterror weapon against
an unvaccinated population and the risk of complications of
vaccinia infections if a prophylactic vaccination program is
resumed.
Materials and methods
vD1(1–545) mutations were programmed by synthetic
oligonucleotides, using the two-stage PCR-based overlap
extension strategy. NdeI–BglII restriction fragments of the
PCR-amplified mutated vD1(1–545) DNAs were inserted
into the T7-based expression plasmid pET16b that had been
digested with NdeI and BamHI. The resulting plasmids
contained the mutated vD1(1–545) coding sequence fused
in frame with a 63-bp 5 leader sequence that encodes 10
consecutive histidines. The presence of the desired muta-
tions was confirmed in each case by sequencing the entire
1.7-kbp insert; the occurrence of PCR-generated mutations
outside the targeted region was thereby excluded.
Cultures (500 ml) of E. coli BL21(DE3)/pet-D1(1–545)
were grown at 37°C in Luria-Bertani medium containing
0.1 mg/ml ampicillin until the A600 reached 0.5. The
cultures were placed on ice for 10 min and then adjusted to
2% (v/v) ethanol. After further incubation for 17 h at 18°C
with constant shaking, the cells were harvested by centrif-
ugation, and the pellets were stored at 80°C. All subse-
quent procedures were performed at 4°C. Thawed bacteria
were resuspended in 20 ml of buffer A (50 mM Tris–HCl,
pH 7.5, 500 mM NaCl, 10% sucrose). Lysozyme was added
to a final concentration of 50 g/ml, and the suspension was
incubated on ice for 15 min and then adjusted to 0.1%
Triton X-100 and sonicated to reduce the viscosity of the
lysate. Insoluble material was removed by centrifugation.
The soluble extracts were applied to 0.6-ml columns of
Ni2–NTA–agarose (Qiagen) that had been equilibrated
with buffer A containing 0.1% Triton X-100. The columns
were washed with the same buffer and then eluted stepwise
with buffer B (50 mM Tris–HCl, pH 8.0, 500 mM NaCl,
10% glycerol, and 0.1% Triton X-100) containing 0, 25, 50,
100, 200, and 500 mM imidazole. The polypeptide compo-
sitions of the column fractions were monitored by SDS–
PAGE. The wild-type and mutant vD1(1–545) proteins
were retained on the column and recovered predominantly
in the 200 mM imidazole fractions, which typically con-
tained 0.5–1 mg of protein. Aliquots (200 g) of the Ni–
agarose preparations were applied to 4.8-ml 15 to 30%
glycerol gradients containing 0.1 M NaCl, 50 mM Tris–HCl
(pH 8.0), 1 mM EDTA, 1 mM DTT, 0.1% Triton X-100.
The gradients were centrifuged for 20 h at 4°C in a Beck-
man SW50 rotor at 50,000 rpm. Fractions (0.18 ml) were
collected from the bottoms of the tubes. The polypeptide
compositions of the column fractions were monitored by
SDS–PAGE. Protein concentrations were determined using
the Bio-Rad dye reagent with bovine serum albumin as a
standard. The peak glycerol gradient fractions of the wild-
type and mutant D1(1–545) proteins were used for all as-
says.
Guanylyltransferase reaction mixtures (20 l) containing
50 mM Tris–HCl (pH 8.0), 5 mM DTT, 5 mM MgCl2, 5
M [32P]GTP, and wild-type or mutant vD1(1–545) as
specified were incubated for 5 min at 37°C. The reactions
were quenched with SDS and the products were analyzed by
SDS–PAGE. The covalent enzyme–[32P]GMP complex was
visualized by autoradiography of the dried gel and quanti-
tated by scanning the gel with a phosphorimager.
Triphosphatase reaction mixtures (10 l) containing 50
mM Tris–HCl (pH 8.0), 5 mM DTT, 10 mM MgCl2, 1 mM
[32P]ATP, and serial two-fold dilutions of enzyme as spec-
ified were incubated for 30 min at 37°C. The reaction
products were analyzed by polyethyleneimine–cellulose
thin-layer chromatography (TLC) with 0.5 M LiCl, 1 M
formic acid buffer. The release of 32Pi was quantitated by
scanning the TLC plate with a phosphorimager.
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